COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,763 Articles (22,502 medRxiv, 8,261 bioRxiv)

Most recent first Previous |  Page 980: Articles 9791-9800  | Next

Relationship between temperature and relative humidity on the initial spread of COVID-19 cases and deaths in Brazil
Olinto, M. T. A., Garcez, A., Brunelli, G., Olinto, F. A., Fanton, M., Canuto, R.
10.1101/2021.12.26.21268421 — Posted: 2021-12-29
Replacement of the Gamma by the Delta variant in Brazil: impact of lineage displacement on the ongoing pandemic
Giovanetti, M., Fonseca, V., Wilkinson, E., Tegally, H., San, E. J., Althaus, C. L., Xavier, J., Nanev Slavov, S., Viala, V. L., Ranieri Jeronimo Lima, A., Ribeiro, G., Souza-Neto, J. A., Fukumasu, H., Lehmann Coutinho, L., Venancio da Cunha, R., Freitas, C., Campelo de A e Melo, C. F., Navegantes, W., do Carmo Said, R. F., Almiron, M., de Oliveira, T., Sampaio, S. C., Elias, M. C., Tadeu Covas, D., Holmes, E. C., Lourenco, J., Kashima, S., Alcantara, L. C. J.
10.1101/2021.12.27.21268309 — Posted: 2021-12-29
Waning of SARS-CoV-2 booster viral-load reduction effectiveness
Levine-Tiefenbrun, M., Yelin, I., Alapi, H., Herzel, E., Kuint, J., Chodick, G., Gazit, S., Patalon, T., Kishony, R.
10.1101/2021.12.27.21268424 — Posted: 2021-12-29
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (BBV152) in children from 2 to 18 years of age: an open-label, age-de-escalation phase 2/3 study
Vadrevu, K. M., Reddy, S., Jogdand, H., Ganneru, B., Mirza, N., Tripathy, V., Singh, C., Khalatkar, V., Prasanth, S., Rai, S., Ella, R., Blackwelder, W., Prasad, S., Ella, K.
10.1101/2021.12.28.21268468 — Posted: 2021-12-29
Effects of COVID-19 on the human central olfactory system: a natural pre-post experiment
Thunell, E., Peter, M. G., Lenoir, V., Andersson, P., Landis, B. N., Becker, M., Lundstrom, J. N.
10.1101/2021.12.27.21268455 — Posted: 2021-12-29
A preliminary study of commercially available general-purpose chest radiography artificial intelligence-based software for detecting airspace opacity lesions in COVID-19 patients
Suzuki, M., Niimura, A., Nakamura, Y., Otsuka, Y.
10.1101/2021.12.22.21268176 — Posted: 2021-12-29
Neutralizing antibody responses to SARS-CoV-2: a population based seroepidemiological analysis in Delhi, India
Sharma, P., Gupta, E., Basu, S., Aggarwal, R., Mishra, S., Kale, P., Mundeja, N., Charan, B. S., Singh, G. K., SINGH, M. M.
10.1101/2021.12.28.21268472 — Posted: 2021-12-29
Evolution of COVID-19 Health Disparities in Arizona
Shen, F. L., Shu, J., Lee, M., Oh, H., Marsiglia, F., Li, M., Runger, G., Liu, L.
10.1101/2021.12.27.21268462 — Posted: 2021-12-29
SARS-CoV-2 seroprevalence in Delhi, India: September October 2021: a population based seroepidemiological study
Sharma, P., Basu, S., Mishra, S., Gupta, E., Aggarwal, R., KALE, P. R., Mundeja, N., Charan, B. S., Singh, G. K., Singh, M. M.
10.1101/2021.12.28.21268451 — Posted: 2021-12-29 Discussion: Onsite
Predicting the course of Covid-19 and other epidemic and endemic disease
Cascon, A., Shadwick, W. F.
10.1101/2021.12.26.21268419 — Posted: 2021-12-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).